St. John's Wort: Real Effectiveness, Major Drug Interactions and Precautions

St. John's wort (Hypericum perforatum) is a plant studied for certain mild to moderate depressive symptoms. It is also one of the medicinal plants whose drug interactions are best documented and potentially most serious: it can reduce the effectiveness of many essential treatments, sometimes with serious consequences.

• Trials suggest effectiveness comparable to that of certain SSRI antidepressants in mild to moderate depression, generally with fewer side effects.
• St. John's wort stimulates liver enzymes and a transporter (P-glycoprotein) that speed up the elimination of many medications: hormonal contraceptives, anticoagulants, immunosuppressants, certain HIV or cancer treatments, digoxin.
• A historic case of acute heart transplant rejection, directly linked to this interaction, has left its mark on the medical literature and prompted official warnings.
• Combined with a serotonergic antidepressant, it can cause serotonin syndrome, which can be serious.

St. John's wort corresponds to Hypericum perforatum. Products use the flowering aerial part, as a dried plant, a tea, or standardized dry extracts. Composition varies by botanical species, part used, harvest period, and extraction process: two boxes bearing the same name therefore don't guarantee the same exposure to active compounds, notably hyperforin, considered the main driver of drug interactions, and hypericin.

The European monograph (EMA/HMPC) distinguishes well-established medicinal uses from traditional uses depending on the preparation. This regulatory framework governs certain specific products; it doesn't mean every freely sold supplement is suitable for everyone, nor that it can be used without checking current treatments.

St. John's wort preparations can be of interest in certain mild to moderate depression. A Cochrane review pooling 29 studies and 5,489 participants reported generally favorable results, but with substantial heterogeneity: trials conducted in certain German-speaking countries showed stronger effects than trials conducted elsewhere, which fueled debate about publication bias or regional methodology.

More recently, meta-analyses directly comparing St. John's wort with selective serotonin reuptake inhibitor (SSRI) antidepressants in mild to moderate depression found no significant difference in response or remission rates, with an advantage for St. John's wort on tolerability: fewer side effects and fewer treatment discontinuations due to those effects.

St. John's wort should not replace a prescribed treatment, nor delay a consultation for depressive symptoms, and even less so for severe depression or suicide risk, situations where its effectiveness isn't established in the same way. Worsening mood, suicidal thoughts, unusual agitation, or severe symptoms require urgent medical help, not a trial of herbal medicine.

St. John's wort, mainly via hyperforin, stimulates a nuclear receptor (PXR) that in turn activates liver enzymes (notably CYP3A4) and P-glycoprotein, a transporter that limits absorption or promotes the elimination of many substances. In practice, it speeds up the breakdown or reduces the absorption of numerous medications, which lowers their blood concentration, sometimes below the effective threshold.

A case that became a medical reference point

This interaction isn't theoretical. A widely cited case in the medical literature concerns a person who had received a kidney and pancreas transplant, on cyclosporine (an immunosuppressant), stable since the transplant. After four to eight weeks of self-medicating with St. John's wort, blood concentrations of cyclosporine became insufficient, which was associated with organ rejection; concentrations returned to therapeutic levels four weeks after stopping St. John's wort. A similar case of acute heart transplant rejection has also been published. These cases led to official warnings about combining St. John's wort with immunosuppressants after transplantation.

The major drug categories affected

Reduced effectiveness of these treatments can have serious consequences: contraceptive failure, transplant rejection, loss of anticoagulant effect with a risk of blood clots, or a diminished effect of a life-saving treatment. This is one of the reasons why St. John's wort, despite its status as a "plant," should never be considered a harmless product to freely add to an existing treatment.

Serotonin syndrome: the other side of the risk

Combined with a serotonergic antidepressant (SSRI, SNRI), a triptan, or certain painkillers like tramadol, St. John's wort can amplify serotonergic effects and expose someone to serotonin syndrome. Agitation, confusion, heavy sweating, a racing heart, diarrhea, fever, tremors, or muscle rigidity after such a combination call for prompt medical advice, or even an emergency room visit if symptoms are marked.

In the absence of sufficient safety data, pregnancy and breastfeeding require professional advice before any use; self-medicating with a concentrated supplement is discouraged as a precaution, especially since possible interactions with other treatments taken during pregnancy add another layer of complexity.

Particular caution is needed in the case of any chronic treatment, liver disease, bipolar disorder (St. John's wort can promote a manic switch in a predisposed person) or psychotic disorder, an organ transplant, autoimmune disease, or taking several medications at once. Children should not be given a preparation without medical advice.

St. John's wort can increase skin sensitivity to sunlight (photosensitization), an effect more pronounced in fair-skinned people, at a high dose, or with prolonged sun exposure. Digestive or neurological side effects are also possible: nausea, diarrhea, dizziness, agitation, or sleep disturbances, to be taken seriously especially if the product is concentrated or combined with other active substances.

The safety profile depends heavily on the preparation and the hyperforin content. It would therefore be unwise to infer the safety of a concentrated, high-dose extract from that of a mild tea: in practice, these are two different exposures that share only a common name.

Labels like "natural," "mood plant," or "wellbeing support" are neither guarantees of effectiveness nor of safety. A study conducted on a specific extract, at a specific dose, doesn't automatically validate another capsule on the market. A formula advertised as "low in hyperforin" doesn't allow you to ignore concurrent treatments: the European monograph and expert opinions instead emphasize the complexity and variability of this risk depending on the product.

• "It's a plant, so it's gentler than an antidepressant." On effectiveness in mild to moderate depression, the data place it close to SSRIs; on interactions, it can be more problematic than many synthetic medications.
• "I can try it alongside my treatment, it can't hurt." The opposite is true for many treatments: contraception, anticoagulants, immunosuppressants, and antidepressants are precisely the most exposed.
• "A mild tea doesn't carry the same risks as a concentrated capsule." That's partly true for intensity, but the same precautionary principle applies: the hyperforin content of a homemade tea isn't controlled.
• "If my pharmacist didn't say anything, my product must be safe with my medications." A pharmacist can only check an interaction if they know about the St. John's wort: it's up to the person to actively mention it, including for a supplement bought without a prescription.

St. John's wort is a studied plant, with a genuine effectiveness signal in certain mild to moderate depression, comparable to that of some conventional antidepressants and generally better tolerated. But this benefit comes with one of the most well-documented interaction risks in all of herbal medicine, with potentially serious consequences: contraceptive failure, transplant rejection, loss of anticoagulant effect, serotonin syndrome. The absolute priority is to never self-medicate without having the product and the full list of current treatments checked by a health professional.